Holdings Channel
Size ($ in 1000's)
At 12/31/2023: $1,435,505
At 09/30/2023: $949,946

VR Adviser LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from VR Adviser LLC 13F filings. Link to 13F filings: SEC filings

VR Adviser LLC Top Holdings
As of  12/31/2023, below is a summary of the VR Adviser LLC top holdings by largest position size, as per the latest 13f filing made by VR Adviser LLC. In the VR Adviser LLC-top-holdings-table below, each of the top holdings by name is presented in the first column, followed by the amount of shares held by VR Adviser LLC in that top holding, then the share count change between reporting periods, and finally the VR Adviser LLC top holding position size for that row.

   EntityAmountChange
 09/30/2023 to 12/31/2023
Position Size
($ in 1000's)
RAYZEBIO INC 4,030,471 +13,624 $250,574
     RYZB4,030,471+13,624$250,574
APOGEE THERAPEUTICS INC 8,493,321 UNCH $237,303
     APGE8,493,321UNCH$237,303
PHARVARIS N V 3,395,606 +1,832,093 $95,247
     PHVS3,395,606+1,832,093$95,247
VIRIDIAN THERAPEUTICS INC 3,882,623 +800,001 $84,564
     VRDN3,882,623+800,001$84,564
4D MOLECULAR THERAPEUTICS IN 3,424,031 +424,031 $69,371
     FDMT3,424,031+424,031$69,371
MERUS N V 2,148,214 +422,000 $59,076
     MRUS2,148,214+422,000$59,076
CABALETTA BIO INC 2,563,952 +590,699 $58,202
     CABA2,563,952+590,699$58,202
KALVISTA PHARMACEUTICALS INC 4,092,731 +1,176,064 $50,136
     KALV4,092,731+1,176,064$50,136
ENLIVEN THERAPEUTICS INC 2,954,902 UNCH $40,896
     ELVN2,954,902UNCH$40,896
OCULAR THERAPEUTIX INC 7,775,760 +7,775,760 $34,680
     OCUL7,775,760+7,775,760$34,680
HILLEVAX INC 2,075,000 +37,687 $33,304
     HLVX2,075,000+37,687$33,304
AMBRX BIOPHARMA INC 2,070,000 UNCH $29,477
     AMAM2,070,000UNCH$29,477
TERNS PHARMACEUTICALS INC 4,497,117 +1,404,844 $29,186
     TERN4,497,117+1,404,844$29,186
DYNE THERAPEUTICS INC 2,173,913 UNCH $28,913
     DYN2,173,913UNCH$28,913
SPYRE THERAPEUTICS INC 2,372,714 +2,077,680 $28,496
     AGLE2,372,714+2,077,680$28,496
COGENT BIOSCIENCES INC 4,684,167 UNCH $27,543
     COGT4,684,167UNCH$27,543
CELCUITY INC 1,885,538 -219,848 $27,472
     CELC1,885,538-219,848$27,472
MERSANA THERAPEUTICS INC 11,328,000 UNCH $26,281
     MRSN11,328,000UNCH$26,281
ARVINAS INC 627,788 +627,788 $25,840
     ARVN627,788+627,788$25,840
ASTRIA THERAPEUTICS INC 3,225,806 +3,225,806 $24,774
     ATXS3,225,806+3,225,806$24,774
RHYTHM PHARMACEUTICALS INC 495,983 -594,017 $22,800
     RYTM495,983-594,017$22,800
ORIC PHARMACEUTICALS INC 2,428,385 +285,529 $22,341
     ORIC2,428,385+285,529$22,341
APPLIED THERAPEUTICS INC 6,250,000 +591,966 $20,938
     APLT6,250,000+591,966$20,938
TAYSHA GENE THERAPIES INC 10,412,872 -4,031,572 $18,431
     TSHA10,412,872-4,031,572$18,431
SAVARA INC 3,500,000 -3,684,865 $16,450
     SVRA3,500,000-3,684,865$16,450
LYRA THERAPEUTICS INC 2,575,593 +1,651,423 $13,496
     LYRA2,575,593+1,651,423$13,496
ABIVAX SA 998,570 +998,570 $10,685
     ABVX998,570+998,570$10,685
DIANTHUS THERAPEUTICS INC 927,706 UNCH $9,648
     DNTH927,706UNCH$9,648
PRAXIS PRECISION MEDICINES I 353,626 -4,950,784 $7,879
     PRAX353,626-4,950,784$7,879
GH RESEARCH PLC 1,318,327 -1,425,798 $7,646
     GHRS1,318,327-1,425,798$7,646
ACELYRIN INC 937,113 +72,781 $6,991
     SLRN937,113+72,781$6,991
EYEPOINT PHARMACEUTICALS INC 250,000 +250,000 $5,778
     EYPT250,000+250,000$5,778
TREVI THERAPEUTICS INC 3,422,397 UNCH $4,586
     TRVI3,422,397UNCH$4,586
ADVERUM BIOTECHNOLOGIES INC 5,147,547 -1,425,753 $3,875
     ADVM5,147,547-1,425,753$3,875
MILESTONE PHARMACEUTICALS IN 925,048 -1,283,764 $1,545
     MIST925,048-1,283,764$1,545

See Full List: All Stocks Held By VR Adviser LLC
— Including:
     • Biggest new positions
     • Biggest exits
     • Biggest increased positions
     • Biggest decreased positions

See Details: Top 10 Stocks Held By VR Adviser LLC

VR Adviser LLC Top Holdings 13F Filings | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.